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Background: Cerebral air microembolization (CAM) is a frequent side effect of diagnostic or therapeutic interventions.
Besides reduction of the amount of bubbles, filter systems in the clinical setting may also lead to a dispersion of large
gas bubbles and therefore to an increase of the gas–liquid-endothelium interface. We evaluated the production and
application of different strictly defined bubble diameters in a rat model of CAM and assessed functional outcome and
infarct volumes in relation to the bubble diameter.
Methods: Gas emboli of defined number and diameter were injected into the carotid artery of rats. Group I (n = 7)
received 1800 air bubbles with a diameter of 45 μm, group II (n = 7) 40 bubbles of 160 μm, controls (n = 6) saline
without gas bubbles; group I and II yielded the same total injection volume of air with 86 nl. Functional outcome was
assessed at baseline, after 4 h and 24 h following cerebral MR imaging and infarct size calculation.
Results: Computer-aided evaluation of bubble diameters showed high constancy (group I: 45.83 μm± 2.79; group II:
159 μm± 1.26). Animals in group I and II suffered cerebral ischemia and clinical deterioration without significant
difference. Infarct sizes did not differ significantly between the two groups (p = 0.931 u-test).
Conclusions: We present further development of a new method, which allows reliable and controlled CAM with
different bubble diameters, producing neurological deficits due to unilateral cerebral damage. Our findings could not
display a strong dependency of stroke frequency and severity on bubble diameter.
Keywords: Animal experimentation, Cerebral infarction, Cardiopulmonary bypass, Cardiac surgical procedures,
Gas embolismBackground
Cerebral air microembolization (CAM) as an iatrogenic
event represents a well-known complication of various
invasive medical interventions. In the fields of open-heart
surgery, neurosurgery, and diagnostic or therapeutic neu-
roradiology, CAM contributes to increased periprocedural
morbidity and mortality, warranting the development of
preventive strategies [1-3].
Severe CAM, i.e. large volume cerebral air embolization,
is a rare condition that results in severe brain damage.* Correspondence: Tibo.Gerriets@neuro.med.uni-giessen.de
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distribution, and reproduction in any mediumAccording to clinical observations and animal studies,
fatality caused by the infusion of large gas volumes
seems to be undisputable [4,5]. To date, the consequences
of CAM with small amounts of embolized air are still
unknown. Frequently seen in cardiopulmonary bypass
(CPB) assisted surgery or angiography, CAM can lead
to persistent focal neurological and neuropsychological
deficits, often without the display of manifest cerebral
infarction on MRI [2,6]. Recent clinical trials suggest that
the diminution of CAM can improve neuropsychological
outcomes within the first three months post intervention
[2]. Pathophysiological background, thresholds for emboli
load, and other determinants of clinical outcome after
embolization are largely unknown.
Mechanisms of CAM-induced tissue damage exceed
mere mechanical consequences such as compressionntral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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blood flow by a lodging bubble [7]: Constituting a foreign
substance, air bubbles provoke clotting activation [8-11],
inflammatory response with neutrophil aggregation and
complement activation [12,13] with the production of
radical species leading, amongst others, to an increased
vascular permeability and triggering a complex immuno-
logical and ischemic cascade of tissue injury. These
pathomechanisms are initiated on the surface of the
bubble with the gas–liquid-endothelium interface as a
driving force [7].
The use of filter systems during CPB-assisted surgery
can reduce the amount of gaseous cerebral emboli, but
it seems conceivable that the mesh-like structure of
these filters may also cause a dispersion of large gas
bubbles into numerous smaller particles. This would
substantially increase the total bubble surface and,
therefore, intensify the potentially hazardous gas–liquid-
endothelium contact in turn. Not least because of the
absence of an appropriate animal model and the inability
to control and monitor the diameter of the bubbles,
knowledge of cerebral air embolism is sparse and little
is known about the influence of bubble size [14].
Based on the hypothesis that bubble size has an impact
on the neurological outcome and the occurrence of
cerebral ischemia following CAM, we aimed to prove
feasibility and reliability of production as well as application
of gaseous bubbles with different defined bubble diameters
by means of a recently developed custom-made bubble
generator [15]. Furthermore, we evaluated embolization
effects with regard to the functional neurological outcome,
frequency and volume of cerebral ischemia in relation to
bubble diameter.Figure 1 Schematic diagram of the custom-made bubble generator. C
the variation of airflow, saline flow, diameter, and position of the capillary w
bubble number and size is performed using a high-speed optical image caMethods
Production and application of microbubbles
For the production and application of air microbubbles,
we used a custom-made device, as previously established
by our group [15]: the device consists of a customized
glass capillary with a diameter of 15-40 μm, positioned
in a larger glass tube with a diameter of 450 μm
(Rincaps, Hirschmann Laborgeraete GmbH) and a
slight taper on one side (Figure 1). The space between
these two tubes was jetted with saline at a constant
flow of 20 ml/h driven by an infusion pump (MC
Medizintechnik GmbH, Alzenau). Simultaneously, air
at a precisely adjustable pressure, controlled by a
regulator (Watson Smith Ltd., Leeds, England), was
piped through the inner capillary, requiring pressure from
0.5 to 1.5 bar to vary the number of produced bubbles.
The number and size of air bubbles were carefully
adjusted at a constant rate before the device was
connected to the carotid artery of the rat. During this
process, a hydrostatic pressure was obtained within
the system simulating the physiological mean arterial
blood pressure of each animal under anesthesia. After
adjustment, a glass valve between the Teflon tubing and
the glass tube was opened and saline with air bubbles
was allowed to flow into the carotid artery of the rat,
joining the bloodstream.
Quantification of the number and size of air microbubbles
The bubble formation was recorded by a high-speed
optical image capturing system (Camera A602f-2, Basler,
Switzerland) focusing on the tapering (Figure 1) and
connected to a personal computer (MacBook Pro, Mac
OS X, version 10.5.1). A custom-made software allowedontrolled alteration of air bubble number and size can be obtained by
ithin the outer tube. Automatic recording and determination of
pturing system connected to a computer with custom-made software.
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of the air bubbles flowing into the carotid artery of the
animal.
Animal preparation
All procedures were carried out in accordance with our
institutional guidelines and the German animal protection
legislation and were approved by the regional ethics
committee (Regierungspraesidium Darmstadt; AZ B2/203).
Twenty male Wistar Unilever rats (HsdCpb:WU; Harlan
Winkelmann, Borchen, Germany) were anesthetized with
5% isoflurane in an enclosed chamber. During surgery,
anesthesia was maintained with 2-3% isoflurane delivered
in air at 0.5 l/min through a closely fitting facemask under
sustained spontaneous breathing. Analgesia was achieved
by subcutaneous injection of Carprofen 5 mg/kg (Rimadyl,
Pfizer, Germany) 30 min prior to surgery. During these
procedures, the body temperature of the rat was continu-
ously monitored with a rectal probe and maintained at
36.5-37°C with a thermostatically controlled heating pad.
The right common carotid (CCA), internal carotid (ICA),
and external carotid artery (ECA) were exposed by a
midline incision of the neck. After isolation of the
ECA, the superior thyroid and occipital arteries were
cauterized. Then the distal portion of the ECA was
ligated with a 5–0 suture and intersected to create an
ECA stump with a length of approximately 5 mm. Fur-
thermore, the pterygopalatine branch of the ICA was
ligated with a 5–0 suture.
Application of air bubbles to cerebral circulation
The Teflon-50 tubing (Figure 1) was deaerated, connected
with the air bubble generator, and then inserted into
the ECA stump through an arteriotomy. To ensure the
free movement of the air bubbles with the current of
the physiological blood stream from the CCA to the
ICA, the tip of the tubing was placed close to the
carotid bifurcation under visual control. Unintended
inlet of air was avoided by fixation of the tubing within
the ECA stump through ligature and controlled optically
via the surgical microscope during the whole injection
procedure.
To minimize total injection volume, we chose the lowest
infusion speed carrying the air bubbles appropriately: the
infusion was performed within approximately 2 minutes
at a speed of 20 ml/h, equivalent to an infusion volume of
approximately 0.65 ml saline per animal. A PE-50-catheter
was inserted into the tail artery from 30 minutes before
until 30 minutes after carotid artery infusion in order
to monitor the arterial blood pressure and obtain blood
samples for arterial blood gas analysis. After air infusion,
the ECA was ligated, the tubing removed, and the wounds
closed carefully. Then the animals were allowed to recover
from anesthesia.Functional testing
Functional testing was performed by investigators blinded
to group assignment at baseline, after 4 h, and after
24 h using a Neuroscore, as previously described by
Nedelmann et al., and the Rotarod test: The Neuroscore
assesses dimensions of motor, coordinative, and sensory
function by testing contralateral forelimb flexion, hemi-
anopia, sensory to left side touch, instability to lateral
push from the right, and coordination when walking on
the ground. For each item, up to 10 points can be allocated.
The Neuroscore can range from 0 (no deficit) to 90 (very
severe neurological deficit) [16].
During Rotarod testing, the wheel was continuously
accelerated from 0 to 30 rpm within one minute. The
maximum speed tolerated by the rats without falling off
or spinning around was documented [17].
MR imaging
MR imaging was carried out 24 hours after intervention.
Animals were fixed in a body restrainer with a tooth bar
and a cone-shaped head holder and placed in an MRI
tomograph (Bruker PharmaScan 7.0 T, 16 cm, Ettlingen,
Germany), which operates at 300.51 MHz for 1H-imaging
and is equipped with a 300 mT/m self-shielding gradient
system.
The respiratory rate (50-70/min) was monitored with
a pressure probe placed between the restrainer and the
animal’s thorax. Anesthesia was maintained with isoflurane
delivered in air at 0.5 L/min. The isoflurane concentration
was varied between 2.0% and 3.0% to keep the respiratory
rate between 35 and 45/min. The temperature was
monitored using a rectal probe and maintained at 37°C by
a thermostatically regulated water flow system throughout
the imaging protocol.
A Carr-Purcell-Meiboom-Gill spin echo imaging se-
quence was used to map lesion and hemisphere volumes.
Six contiguous coronal slices with a thickness of 2 mm
(gap of 0 mm) were acquired (Field of view 37 × 37 mm,
matrix 512 × 256, repetition time 3833.5 msec, 12 echoes:
echo time 18–216 msec (Δ echo time 18 msec), acquisi-
tion time 16.25 minutes, number of excitations 1).
The T2-relaxation time was measured in regions of
interest within the center of the ischemic area on all
slices displaying ischemic lesions and a corresponding
position on the contralateral hemisphere. The difference in
T2RTs between the ischemic and unaffected hemispheres
was calculated.
Computer aided planimetric assessment of ischemic
lesion volumes and hemispheric volumes were performed
by two blinded investigators experienced in experimental
stroke MRI. The ipsilateral and contralateral hemispheric
volume and lesion volume on T2WI were determined
using the Image J 1.25 s image analysis software (National
Institutes of Health, USA). The edges of the hemispheres
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landmarks. Hyperintense ischemic lesions were traced
manually in a similar fashion. The areas were then
summed and multiplied by the slice thickness to calculate
volumes. Lesion volumes were calculated with and
without edema correction and expressed as a percentage
of the hemispheric volume as described previously [18]:
%HLVuc ¼ LV= HVcþHVið Þ=2ð Þ  100Þ
%HLVec ¼ HVc2þ LV  HVcþHVið Þ–HVi2ð Þ=
HVc  HVcþHVið Þð Þ  100
(%HLVuc = percent hemispheric lesion volume – not
corrected for edema; %HLVec = percent hemispheric
lesion volume – corrected for edema; HVc = volume of the
contralateral hemisphere; HVi = volume of the ipsilateral
hemisphere; LV = lesion volume)
Experimental protocol
Twenty rats (body weight 300-347 g) were randomized
into 3 groups: the animals in group I (n = 7) received
1800 air bubbles with a low target diameter of 45 μm.
Group II (n = 7) received 40 air bubbles with a higher
target diameter of 160 μm, yielding equal total volume
of administered air per rat of 86 nl in both groups. The
animals in Group III (n = 6) served as sham-operated
controls with the infusion of an identical volume of saline
without application of air bubbles. Functional testing
was performed at baseline, at 4 h, and at 24 h after
intervention, followed by MRI examination.
Statistical analysis
The Kolmogorov–Smirnov Test was used to test for
normal distribution of data; homogeneity of variance
was tested by Levene-Test. Group differences were
tested by non-parametric Kruskal-Wallis Test. Then the
individual groups were subjected to subsequent post-hoc
analysis with Mann-Witney-U Test. The p-value p < 0.05
was considered statistically significant. The data are
presented as mean ± standard deviation.
Results
Four animals had to be excluded from analysis: one animal
in group I received bubbles with a mean diameter
much higher than the target size of 45 μm due to technical
problems in adjusting the bubble size. During bubble
injection of an animal in group II, flow problems occurred
and bubbles conglomerated at the tip. Another rat in
group II died 5 hours after the intervention. A fourth
animal showed severe hemodynamic instability as well
as apneas during saline application. The remaining sixteen
animals (group I n = 6, group II n = 5, group III n = 5)
survived and completed the study protocol.Reliability of air bubble generation
For the present experiment, we selected two groups with
target air bubble diameters of 45 and 160 μm compared
to a sham-operated control group. The actual bubble
sizes, as determined by the computer-aided camera system,
were 45.83 μm±2.79 (range 42-49 μm) and 159 μm± 1.26
(range 157-160 μm). The effective bubble count injected
into the carotid artery averaged out at 1808.5 ± 11.04 in
group I and 40.17 ± 0.41 in group II.
Functional outcomes
In the sham-infusion group, no pathological findings in
Neuroscore performance were detectable. Animals in
groups I and II showed clinical deterioration after bubble
infusion as determined by the Neuroscore: In group I,
the mean neurological score was 15 ± 11.83 after 4 h
and 10 ± 5.47 after 24 h, and in group II, it was 19.17 ±
11.14 after 4 h and 19 ± 10.24 after 24 h. Compared to
the control group (III), these findings appeared to be
statistically significant. However, between the two bubble
sizes of 45 and 160 μm, differences after 4 h (p = 0.931)
and 24 h (p = 0.177) did not reach statistical significance.
In animals of all groups, the Rotarod performance
worsened slightly after injection. At baseline, the mean
maximum speed tolerated by the animals of group I
was 23 ± 4.52 rpm; at 4 h and 24 h after intervention,
test performance decreased to 21 ± 7.35 rpm for both
time points. Animals in group II tolerated a mean speed of
22 ± 3.10 rpm at baseline (p = 0.664), 19 ± 11.01 rpm after
4 h (p = 0.792), and 20.4 ± 10.90 rpm after 24 h (p = 0.931).
Between these two groups, no statistical significance could
be detected.
Cerebral infarction on MRI
According to T2-weighted MR imaging after 24 h, no
cerebral infarction could be detected in the control group
(III). The infusion of air bubbles with a diameter of 45 μm
(group I) and 160 μm (group II) resulted in ischemic
infarction within the vascular territory supplied by the
right internal carotid artery of four animals in each
group (Figure 2 and 3). The assessment of infarct size
showed a mean ischemic affected hemispheric volume
of 5.18 ± 8.91% in group I and 2.48 ± 3.65% in group II,
achieving no statistical significance (p = 0.931, Figure 3).
Discussion
CPB-assisted surgical interventions remain one of the most
important causes of CAM; thus, filter systems have been
suggested to reduce the number of bubbles. Common
filters are installed in the arterial line of extracorporeal
circulation, acting as a strainer by trapping bubbles that are
larger than its pores [19,20]. However, besides increasing
resistance to the flow itself, progressive filling with debris
and fibrin, activation of coagulation cascade, and the
Figure 2 Cerebral MRI. Representative examples of T2-weighted MRI 24 h after embolization of small (1st row) or large (2nd row) bubbles. Note
the arrows indicating cortical and subcortical ischemic lesions displayed in white.
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the structure of these filters causes dispersion of larger
bubbles into numerous smaller ones. In consequence, this
would increase the gas–liquid-endothelial interface, which
is known to be a significant factor of CAM-mediated
tissue damage by activation of inflammatory response,
the complement as well as the clotting system [7-13].
Hence, it is reasonable to proof whether bubble size has
an impact on the neurological outcome or the occurrence
of cerebral infarction and if markedly expanded regions
of ischemia may reflect the extensive increase of the
gas–liquid-endothelium contact interface in turn.
For decades, technical problems hampered standardized
and reliable investigation of cerebral air embolism in basic
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Figure 3 Number and size of cerebral infarction. Four animals in each
expressed as the edema-corrected hemispheric lesion volume differed notdisruption of physiological blood circulation, excessive
volume of the air embolus, and varying bubble size [21].
Most of these problems could be solved, but bubble sizes
remained difficult to control: Nearly all animal studies on
cerebral air embolism have used the injection of different
volumes of air as a bolus or repetitively and titrated to
a certain extent of damage without the opportunity to
display and verify bubbles and their size [14,22-26].
To investigate the impact of bubble size, we used our
recently established rat model for air microembolism
allowing the application of gaseous bubbles under pre-
served physiological cerebral blood flow [15]. In the
past, investigations on CAM revealed a dose-dependent
toxicity of air volume and functional parameters: Gerriets
et al. (2010) used a bubble diameter of 160 μm with an4 2,48 
 m (group II) 
er 
31 
Number of animals 
with infarct 
%HLVec 
group suffered cerebral infarction detectable on MRI. Infarct sizes,
statistically significant (5.18 ± 8.91% vs. 2.48 ± 3.65%, p = 0.931 u-test).
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outcomes at higher gas emboli counts [15]. Jungwirth
et al. (2007) revealed a dose-dependent relationship
between CAM and survival, neurological outcome, and
histological outcome [24]. The present study compares
two different bubble sizes yielding the same total injection
volume of 86 nl, which -according to findings from
preliminary experiments- seems to represent a vulnerable
threshold for the reproducible provocation of cerebral
infarction in a rat brain [15]. Technically, the custom-made
device we used is able to produce bubbles with a diameter
of 40-250 μm. Herein, we chose 45 μm for small bubbles
and 160 μm for the larger ones, representing two different
sizes within the range that our device can produce [15].
With respect to the number and diameter of gaseous
bubbles, we could demonstrate feasible and highly reliable
production and injection of small 45 μm-bubbles with
a low standard deviation.
We were able to show that functional performance
according to the Neuroscore worsened significantly
after embolization when compared to the sham-operated
rats. The tendency to larger bubbles leading to a worse
functional outcome has to be interpreted with caution,
because scores showed broad standard deviations and
differences did not reach statistical significance here,
which may be attributed to the low number of animals
used. In our experiment, air microembolism regularly
caused cerebral ischemic infarction for both bubble sizes,
though differences in frequency of ischemia between
group I and II could not be verified. Due to the extensive
increase of bubble surface with smaller bubbles and the
suspected noxiousness of the gas–liquid-endothelium
contact, we considered ischemic infarction to increase
in a comparable order of magnitude. The size of ischemic
lesions, as detected by the MRI scan, appeared to be
almost doubled for small bubbles; though, differences
in lesion volume between the two groups did not reach
statistical significance. In summary, we could not find
any significant differences between the two bubble sizes
concerning functional outcome parameters, number of
infarctions, or lesion volume, despite a 45-fold increase
in the number of bubbles, i.e. a 4-fold increase of total
bubble surface respectively, in the 45 μm group.
Besides statistical caveats due to a reduced statistical
power, further pathophysiological considerations may
explain the absence of distinct effects: It seems to be
reasonable but not proven that bubbles of different
size will get stuck analogously in vessels of different
sizes [14]. According to a dynamic bubble behavior,
bubbles may not maintain their size and split, aggregate
or dissolve during downstreaming within short time. This
may lead to a uniform bubble size within the terminal
vascular bed, causing comparable probability of infarction,
lesion volume, and consecutive functional decline. Fur-thermore, there is experimental evidence that even gas
bubbles small enough to pass through arterioles and the
capillaries without verifiably occluding the vessel can lead
to neurological deficits [22,27,28]. This may be supported
by an observation from the venous system of the lung,
where leukocyte and platelet accumulation around gaseous
bubbles was observed on flowing bubbles [29].
The discrepancy between functional deterioration and
infarct volumes in the intervention groups, supplemented
by the observation that one rat in each intervention group
showed clinical deterioration without displaying cerebral
infarction on MRI, question cerebral ischemia as the only
pathological correlate of CAM-mediated tissue injury.
Clinical studies have revealed that not every patient with
cognitive decline after CPB-assisted surgical intervention
shows morphological changes such as ischemic stroke
detectable by MRI, supposing that the majority of cerebral
damages that become clinically obvious post-intervention
is still beyond the detection level of MRI [2,30-33]. Not
least because of the large number of different existing
animal models, determinants and cut-off points for
morphological or cognitive damage due to subtle CAM
as well as pathophysiological changes with “substructural”
damage are yet undefined and need more experimental
data [7,24]. Our animal model of CAM offers a strongly
controlled setting that may help to define thresholds to re-
produce clinical deterioration without overt morphological
changes in future.
Eliminating bigger bubbles seems to be insufficient to
prevent post-intervention deterioration, and this may
explain why supplements of currently used filter systems
such as the dynamic bubble trap (DBT) lead to better
clinical outcomes. Importantly, the DBT eliminates rather
than fragments gas bubbles. Hence, clinical trials have
shown a reduction of microembolic signals and CAM-
associated effects with filter systems or a combination
of filters with a bubble trap that reduced the number of
bubbles [2,34].
It remains debatable, if the small effect size would have
required higher animal numbers per group to increase
statistical power in the end. As well, limitations of our
study may include the number of dropouts, further
reducing the number of animals completing the study
protocol. There are no data revealing homogeneity of
bubble sizes in the clinical setting or the relation
between harmful bubble sizes and air volume in humans
and animals. Additionally, the animals studied here
were healthy, in contrast to multimorbid patients nor-
mally undergoing CPB-assisted surgery. Beyond that,
susceptibility differences of species to ischemia have
to be taken into account when findings are compared.
There is no denying that even the best animal model
cannot simulate a clinical situation in detail. To con-
centrate on the plain cerebral bubble effect, we rejected
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disturb the stability of vital signs by causing temperature
changes or blood pressure dips, for example [24,35].
Conclusions
Present methodological evaluation revealed the feasibility
of standardized and controlled CAM, producing neuro-
logical deficits due to unilateral cerebral damage with
comparably low mortality. The device used can reliably
produce and inject even small gaseous bubbles with a
diameter of 45 μm. In the context of a small study
group, our findings could not display a strong dependency
of stroke frequency and severity on bubble diameter. A
trend towards larger ischemic infarction with small
bubbles and worse functional outcome with larger bubbles
did not reach statistical significance.
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